OH
ALXN

Oikos Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Oikos Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-24,700
Closed -$3.43M – 5
2018
Q3 		$3.43M Hold
24,700
– – 2.95% 5
2018
Q2 		$3.07M Hold
24,700
– – 1.86% 7
2018
Q1 		$2.75M Hold
24,700
– – 2.17% 7
2017
Q4 		$2.95M Buy
+24,700
New +$3.01M 1.71% 7

Other funds holding ALXN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oikos Holdings's ALXN Position: Q4 2018 in Review

Oikos Holdings sold out of Alexion Pharmaceuticals (ALXN) in Q4 2018, closing a stake of 24,700 shares — an estimated $3.43M sold.

Oikos Holdings first reported a position in ALXN in Q4 2017 and held it in 4 quarters. The position peaked at $3.43M in Q3 2018. 608 funds tracked by Wall St. Rank hold ALXN as of Q4 2018.

  • Oikos Holdings reported no remaining Alexion Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Oikos Holdings sold 24,700 Alexion Pharmaceuticals shares in Q4 2018, an estimated $3.43M.
  • Oikos Holdings first reported a position in Alexion Pharmaceuticals in Q4 2017 and held it in 4 quarters.
  • Oikos Holdings's Alexion Pharmaceuticals position peaked at $3.43M in Q3 2018.
  • 608 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2018.

Based on Oikos Holdings's 13F filing for Q4 2018, filed 11 Feb 2019.